Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

LogiPharma Europe 2024: Envirotainer COO Discusses Reshaping Cold Chain Logistics and Adapting to Disruptions

April 19, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

April 19, 2024

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

April 19, 2024

The latest news for pharma industry insiders.

LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain

April 19, 2024

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis

April 18, 2024

Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.

LogiPharma Europe 2024: Obstacles Surrounding Personalized Therapy Supply Chains

April 18, 2024

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more

April 18, 2024

The latest news for pharma industry insiders.